Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin plus metformin fixed-combination versus monotherapy in drug-naive type 2 diabetes
2006-002794-51Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Vildagliptin + metformin fixed combination, Vildagliptin monotherapy and Metformin monotherapy (3 arms). Primary endpoint: Change from baseline in HbA1c at Week 24. Started Jul 2006; status: completed.
02
Drugs
vildagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002794-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002794-51.